Navigation Links
Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets
Date:7/28/2008

ute at New York University School of Medicine. Dr. Nixon is also Director of Research and the Center for Dementia Research at the Nathan S. Kline Institute for Psychiatric Research.

Rates of Cognitive Impairment Higher Than Anticipated

As the field of Alzheimer's research moves toward earlier treatment and ultimately prevention, it becomes necessary to identify patients at the earliest point in the disease. Mild Cognitive Impairment (MCI) is the term used to describe the intermediate state between normal aging and the very earliest features of Alzheimer's, but its frequency in the population is not known.

Ronald C. Petersen, MD, Ph.D., and colleagues at Mayo Clinic, Rochester, MN, are conducting the Mayo Clinic Study of Aging, which is a longitudinal study of people ages 70 to 89 from Olmsted County, Minnesota. One of the goals of the Study is to follow healthy subjects over time to detect the earliest point of cognitive impairment. In 2004, the researchers recruited 1,786 people who were found to be cognitively normal, and reevaluated them a year later. All subjects underwent a baseline evaluation including an interview of the subject and their study partner by a nurse, a cognitive assessment, and a neurological exam by a physician.

Individuals in the study developed MCI at a rate of about 5.3 percent per year, and this rate was higher with advanced age - about 3.5 percent per year for 70-79 year olds and about 7.2 percent per year for 80-89 year olds. Men were nearly twice as likely to develop MCI as women.

"The rate of new MCI cases in this group was considerably higher than anticipated," Petersen said. "If we extrapolate Alzheimer's incidence rates to MCI, we would expect perhaps 1 to 2 percent per year, but our findings were substantially higher than that."

"These results underscore the urgency of developing new and better strategies to create disease modifying therapies for Alzheimer's. In addition, for public health p
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
2. Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinsons Disease
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
5. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
6. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
7. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
8. Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
9. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
10. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
11. U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 Today MedeAnalytics, a ... the next-generation of its Employer Group and ... plans to provide their employer groups an intuitive ... medical and prescription drug claims, network utilization, and ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group and ...
(Date:6/19/2013)... FRANCISCO , June 19, 2013  It may seem ... possible cure for breast cancer. But these were two of ... Society,s 95 th Annual Meeting & Expo that just ... some are saying this focus by some of the top ... our culture,s obsession with new research that can not only ...
(Date:6/18/2013)...  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ), ... and commercialization of novel bile acid therapeutics to treat ... underwritten public offering of 1,730,000 shares of its common ... share.  In addition, Intercept has granted the underwriters a ... shares of common stock. All of the ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... Aug. 27 Pharmacopeia,(Nasdaq: PCOP ), ... of novel,small molecule therapeutics, announced today that ... Special Program for Research and Training,in Tropical ... novel antimalarial,agents. Pharmacopeia will receive funding to ...
... have started a phase IIa clinical trial designed to ... C viral infection, one,of the toughest infectious diseases in ... which works as a,regulator of the body,s immune response, ... hepatitis C viral infection. "The drugs currently in ...
Cached Medicine Technology:Drug in New Hepatitis C Clinical Trial 2
(Date:6/19/2013)... are increasingly common on college campuses, but are ... up"? A new study by researchers with The ... published online by the Archives of Sexual ... behaviors associated with sexual hookups, particularly among first-year ... negative emotional and physical health outcomes as a ...
(Date:6/19/2013)... 19, 2013 The Movement ... neurosurgeons, psychiatrists and urologists with specialists in physical ... works with patients and their family members to ... of life. Patients also have the opportunity to ... research. , “Movement disorders can be relentlessly progressive ...
(Date:6/19/2013)... Could drugs that block the body,s system for repairing ... to health? As unlikely as it may seem, those ... and breast cancers driven by a mutation in BRCA, ... revealed she carries the mutation. The compounds, termed PARP ... the current edition of Chemical & Engineering News ...
(Date:6/19/2013)... Research Triangle Park, NC (PRWEB) June 19, 2013 ... Entegrion , Inc., announced organizational changes to ... Chairman John B. Mowell said, “To support the ... of Directors has made changes to the Company’s ... advisors.” , The Company announced that ...
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
Breaking Medicine News(10 mins):Health News:Why are some college students more likely to 'hook up'? 2Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2
... University Melvin and Bren Simon Cancer Center will ... health care solutions. WellPoint announced plans in ... to help improve patient care and support physicians ... personalized treatment decisions possible. It is estimated that ...
... the screw. That,s just a part of life for people, ... osteogenesis, a method to correct bone deformities that leave one ... University undergraduates has invented a device they hope will make ... Hospital for Children in Houston, the students came up with ...
... April 23 (HealthDay News) -- It goes without saying that ... they can also be very expensive, an expert warns. ... a person bitten by a venomous snake, said Jill Heatley, ... in College Station. The total cost includes hospitalization, which ...
... SAGE Launch Clinical Psychological Science ,Association for Psychological ... Angeles, CA (April 23, 2012) The Association for ... Clinical Psychological Science , a new peer-reviewed journal focused ... venue for cutting-edge research across a wide range of ...
... and American Associations for Dental Research have published ... articles, titled "Hypoplasia-Associated Severe Early Childhood Caries ... York University College of Dentistry) and "Deciduous Molar ... Elfrink, Academic Centre for Dentistry, Amsterdam) discuss the ...
... Guy, M.D., professor of ophthalmology at Bascom Palmer Eye ... Medicine, has pioneered a novel technological treatment for Leber ... causes rapid, permanent, and bilateral loss of vision in ... Genetic mutations in the mitochondria (part of the ...
Cached Medicine News:Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 2Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 3Health News:Rice University student engineers automate limb lengthening for kids 2Health News:Rice University student engineers automate limb lengthening for kids 3Health News:Cost of Snakebite Therapy May Squeeze Victims' Wallets 2Health News:Association for Psychological Science, SAGE launch Clinical Psychological Science 2Health News:IADR/AADR publish studies on severe early childhood caries - proposes new classification 2Health News:IADR/AADR publish studies on severe early childhood caries - proposes new classification 3Health News:Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder 2
... Wampole Laboratories offers a comprehensive line of ... serum and urine in convenient one-step stick ... 2 testing options. Clearview Easy HCG is ... convenient stick format. Clearview HCG II ...
The BioCheck hCG ELISA is intended for the quantitative determination of human chorionic gonadotropin (hCG) concentration in human serum. The assay is for use in the early diagnosis of pregnancy in a...
... preparation of whole blood is mixed continuously ... cation-exchange resin. During this time, HbAo binds ... a filter separator is used to remove ... contains glycohemoglobin. The percent glycohemoglobin is determined ...
The BioCheck Ferritin ELISA is intended for the quantitative determination of ferritin in human serum. This assay is to be used in the diagnosis of diseases affecting iron metabolism....
Medicine Products: